Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$277M |
| 2 |
Procter & Gamble
PG
|
+$254M |
| 3 |
Advanced Micro Devices
AMD
|
+$189M |
| 4 |
Analog Devices
ADI
|
+$187M |
| 5 |
Home Depot
HD
|
+$166M |
Top Sells
| 1 |
Tesla
TSLA
|
+$2.36B |
| 2 |
Zoom
ZM
|
+$944M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$779M |
| 4 |
Walmart
WMT
|
+$759M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$591M |
Sector Composition
| 1 | Healthcare | 22.93% |
| 2 | Technology | 16.66% |
| 3 | Consumer Staples | 12.21% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Elbit Systems
ESLT
$23.6B
| $2.19M | ﹤0.01% |
18,200
-18,500
| -50% | -$2.23M |
|
2077
SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.78B
| $2.18M | ﹤0.01% |
71,200
-21,900
| -24% | -$670K |
|
2078
Atlanticus Holdings
ATLC
$1.09B
| $2.17M | ﹤0.01% |
182,708
+500
| +0.3% | +$5.95K |
|
|
CAMP
2079
DELISTED
CalAmp Corp.
CAMP
| $2.17M | ﹤0.01% |
13,109
-908
| -6% | -$150K |
|
|
ZUO
2080
DELISTED
Zuora, Inc.
ZUO
| $2.16M | ﹤0.01% |
208,700
-515,000
| -71% | -$5.33M |
|
2081
First Bancorp
FBP
$3.49B
| $2.15M | ﹤0.01% |
412,613
-102,863
| -20% | -$537K |
|
|
RUTH
2082
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $2.15M | ﹤0.01% |
194,500
-1,900
| -1% | -$21K |
|
2083
Data I/O
DAIO
$31.6M
| $2.14M | ﹤0.01% |
674,071
+14,808
| +2% | +$47.1K |
|
|
RNWK
2084
DELISTED
RealNetworks Inc
RNWK
| $2.14M | ﹤0.01% |
1,755,653
+152,605
| +10% | +$186K |
|
2085
Escalade
ESCA
$171M
| $2.14M | ﹤0.01% |
116,965
-29,700
| -20% | -$543K |
|
2086
FB Financial Corp
FBK
$2.86B
| $2.14M | ﹤0.01% |
85,128
+18,528
| +28% | +$465K |
|
2087
Byline Bancorp
BY
$1.33B
| $2.14M | ﹤0.01% |
189,300
-40,300
| -18% | -$455K |
|
2088
Western Alliance Bancorporation
WAL
$9.77B
| $2.13M | ﹤0.01% |
67,504
-72,498
| -52% | -$2.29M |
|
2089
Century Casinos
CNTY
$76.3M
| $2.13M | ﹤0.01% |
388,849
+800
| +0.2% | +$4.38K |
|
|
XHR
2090
Xenia Hotels & Resorts
XHR
$1.41B
| $2.13M | ﹤0.01% |
242,700
-378,600
| -61% | -$3.32M |
|
|
QEP
2091
DELISTED
QEP RESOURCES, INC.
QEP
| $2.13M | ﹤0.01% |
2,359,300
+1,179,701
| +100% | +$1.07M |
|
2092
Dine Brands
DIN
$368M
| $2.13M | ﹤0.01% |
39,000
-56,600
| -59% | -$3.09M |
|
2093
iShares S&P 500 Growth ETF
IVW
$65.4B
| $2.13M | ﹤0.01% |
36,800
+22,000
| +149% | +$1.27M |
|
|
AVYA
2094
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $2.12M | ﹤0.01% |
+139,763
| New | +$2.12M |
|
2095
Caleres
CAL
$503M
| $2.12M | ﹤0.01% |
+221,871
| New | +$2.12M |
|
2096
Artivion
AORT
$1.92B
| $2.12M | ﹤0.01% |
114,625
+97,825
| +582% | +$1.81M |
|
2097
Chemung Financial Corp
CHMG
$252M
| $2.11M | ﹤0.01% |
73,088
-5,000
| -6% | -$144K |
|
2098
Maui Land & Pineapple Co
MLP
$370M
| $2.11M | ﹤0.01% |
194,824
-4,281
| -2% | -$46.3K |
|
2099
Citizens
CIA
$274M
| $2.1M | ﹤0.01% |
379,600
-32,200
| -8% | -$178K |
|
|
INFI
2100
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $2.09M | ﹤0.01% |
1,786,933
+156,295
| +10% | +$183K |
|